Clinical Trial Update: Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients

View source ↗

Summary

A completed medication-use evaluation assessing enoxaparin for venous thromboembolism management in hospitalized COVID-19 patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Methodist Health System | Conditions: Venous Thromboembolism | Status: COMPLETED